MEDISELLERS

Denosumab ( Xgeva Injection ) by Glaxo Smith Kline is a monoclonal antibody. Monoclonal antibodies are made to target and destroy only certain cells in the body. Denosumab is used to treat osteoporosis in postmenopausal women who have high risk of bone fracture.

Xgeva is also used to increase bone mass in women and men with a high risk of bone fracture caused by receiving treatments for certain types of cancer.This may help to protect healthy cells from damage.

Request
Callback